LakeShore Biopharma Co Top Management
| LSBDelisted Stock | 0.63 0.00 0.00% |
LakeShore Biopharma employs about 758 people. The company is managed by 9 executives with a total tenure of roughly 1769 years, averaging almost 196.0 years of service per executive, having 84.22 employees per reported executive. Analysis of LakeShore Biopharma's management performance can provide insight into the company performance.
LakeShore |
LakeShore Biopharma Management Team Effectiveness
The company has Return on Asset of (0.0215) % which means that on every $100 spent on assets, it lost $0.0215. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1843) %, meaning that it generated no profit with money invested by stockholders. LakeShore Biopharma's management efficiency ratios could be used to measure how well LakeShore Biopharma manages its routine affairs as well as how well it operates its assets and liabilities.LakeShore Biopharma maintains a total of 41.21 Million outstanding shares. LakeShore Biopharma Co secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 87.54 % of LakeShore Biopharma Co outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as LakeShore Biopharma in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of LakeShore Biopharma, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
LakeShore Biopharma Workforce Comparison
LakeShore Biopharma Co is rated second overall in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 4,038. LakeShore Biopharma retains roughly 758 in number of employees claiming about 19% of equities under Health Care industry.
The company has Net Profit Margin of (0.16) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.69) %, which entails that for every $100 of revenue, it lost $0.69. LakeShore Biopharma Notable Stakeholders
A LakeShore Biopharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as LakeShore Biopharma often face trade-offs trying to please all of them. LakeShore Biopharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting LakeShore Biopharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Dave Chenn | CoCEO Board | Profile | |
| CFA MBA | President Officer | Profile | |
| MS MBA | Interim Director | Profile | |
| Honggang Teng | Head Management | Profile | |
| Yuan Liu | Head Research | Profile | |
| Zenaida MD | Chief Officer | Profile | |
| Gang Li | Head Sales | Profile | |
| Zhiyuan Ran | Head Department | Profile | |
| Wang Xu | Chief Officer | Profile |
About LakeShore Biopharma Management Performance
The success or failure of an entity such as LakeShore Biopharma often depends on how effective the management is. LakeShore Biopharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of LakeShore management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the LakeShore management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the presentation of LakeShore Biopharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, LakeShore Biopharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of LakeShore Biopharma's management manipulating its earnings.
LakeShore Biopharma Workforce Analysis
Traditionally, organizations such as LakeShore Biopharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare LakeShore Biopharma within its industry.LakeShore Biopharma Manpower Efficiency
Return on LakeShore Biopharma Manpower
| Revenue Per Employee | 811.3K | |
| Revenue Per Executive | 68.3M | |
| Net Loss Per Employee | 131.9K | |
| Net Loss Per Executive | 11.1M | |
| Working Capital Per Employee | 23K | |
| Working Capital Per Executive | 1.9M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in LakeShore Stock
If you are still planning to invest in LakeShore Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LakeShore Biopharma's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |